Gebro Pharma Kft., Hungary
Gebro Pharma GmbH products have been marketed in Hungary through licence partners since as long ago as 1996.
Against this background it was logical to establish our own subsidiary. Gebro Pharma Kft. was founded in March 2007. There has been close co-operation since the development phase with Sager Pharma Kft., a partner of Gebro Pharma GmbH for many years in Hungary.
The following products are marketed in Hungary:
Theospirex® retard 150/300 mg film-coated tablets, Theospirex® ampoules, Alprostapint® 20 mg concentrate for solution for infusion, Seractil® 400 mg film-coated tablets, Nocutil® nasal spray, Nocutil® 0.1/0.2 mg tablets, Halset® lozenges, Hova® film-coated tablets, Normolyt® soluble powder, Metoject® 50 mg/ml 15 mg, Metoject® 50 mg/ml 20 mg, Metoject® 50 mg/ml 25mg.